- 301. D1 receptor
- [A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D1-class receptor genes lack INTRONS, and the receptors stimulate ADENYLATE CYCLASE. ( MSH )] (UMLS (CSP) C0058697) =Amino Acid, Peptide, or Protein; Receptor
| - 351. DACT/DOX/IFF/VCR/VP-16
- (UMLS (NCI) C0281323) =Therapeutic or Preventive Procedure
|
- 302. D1/3 MAGE3 HIS
- [A recombinant, chimeric protein derived from a melanoma antigenic epitope (MAGE-3) and recognized by specific cytotoxic T lymphocytes. MAGE-3, a human peptide epitope present in the cytosol of melanoma cells, may be expressed as the fusion protein D1/3-Mage-3; this fusion protein may boost antitumoral immune responses when used in a vaccine formulation. (NCI04) ( NCI )] (UMLS (NCI) C1327743) D1/3-MAGE-3 Fusion Protein;
D1/3-Mage-3-His Fusion Protein;
D1/3-Mage-3-His Fusion Protein (SB MAGE-3) =Amino Acid, Peptide, or Protein; Pharmacologic Substance | - 352. DACT/DOX/MP/MTX/PRED/VCR
- (UMLS (NCI) C0280821) =Therapeutic or Preventive Procedure
|
- 303. D2 receptor
- [Neurotransmission mediated by the Dopamine D2 Receptor (DRD2) plays a key role in the control of movement, in reward and reinforcement mechanisms in psychiatric disorders, and in the neuromodulation of appetitive behaviors. Acting through D2 dopamine receptors, dopamine specifically inhibits the vascular permeabilizing and angiogenic activities of VEGF by inducing endocytosis of VEGF receptor 2, preventing VEGF binding, receptor phosphorylation, and signaling. ( NCI )] (UMLS (CSP) C0058698) =Amino Acid, Peptide, or Protein; Receptor
| - 353. DACT/DOX/MTX/VCR
- (UMLS (NCI) C0279383) =Therapeutic or Preventive Procedure
|
- 304. D21266
- (UMLS (NCI) C0538860) =Organophosphorus Compound; Pharmacologic Substance
| - 354. DACT/DOX/VCR
- (UMLS (NCI) C0280660) =Therapeutic or Preventive Procedure
|
- 305. D2S123
- [A dinucleotide repeat on chromosome 2 that serves as a marker for microsatellite instability in colorectal cancers. ( NCI )] (UMLS (NCI) C1327772) D2S123 Dinucleotide Repeat =Gene or Genome; ;
| - 355. DACT/IDA/MP/MTX/PRED/VCR
- (UMLS (NCI) C0280729) =Therapeutic or Preventive Procedure ;
|
- 306. D43 grant
- [ ] (UMLS (CSP) C1654780) =Governmental or Regulatory Activity ;
| - 356. DACT/IFF/VCR
- (UMLS (NCI) C0083089) =Therapeutic or Preventive Procedure
|
- 307. d4T/IFN-A/RIT
- (UMLS (NCI) C0393064) =Therapeutic or Preventive Procedure
| - 357. DACT/IFF/VCR/VP-16
- (UMLS (NCI) C0280445) =Therapeutic or Preventive Procedure
|
- 308. D52
- [Expressed in several tissues by human TPD52 Gene (TPD52 Family), 184-aa 20-kDa Tumor Protein D52 exhibits a potential glycosylation site, several potential phosphorylation sites, and homology to N-type calcium channels. TPD52 forms homodimers, or heterodimers with other family members; D52, D53, and D54 share homology, including a coiled-coil domain indicative of protein-protein interactions. D52 may be involved in calcium-mediated signal transduction and cell proliferation. (NCI) ( NCI )] (UMLS (NCI) C0671664) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 358. DACT/TNF
- (UMLS (NCI) C0279428) =Therapeutic or Preventive Procedure
|
- 309. D52-Like 1
- [Expressed in kidney and skin by human TPD52L1 Gene (TPD52 Family), 204-aa 22-kDa Tumor Protein D52-Like 1 exhibits 52% identity to D52, a coiled-coil domain, and PEST domains. D52, D53, and D54 share significant homology, including a coiled-coil domain indicative of protein-protein interactions. TPD52L1 forms homodimers, or heterodimers with other family members. Like D52, TPD52L1 may be involved in calcium-mediated signal transduction and cell proliferation. ( NCI )] (UMLS (NCI) C1314855) D53;
hD53;
TPD52L1;
Tumor Protein D52-Like 1;
Tumor Protein D53;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 359. DACT/VCR
- (UMLS (NCI) C0280659) =Therapeutic or Preventive Procedure
|
- 310. D5S346
- [A dinucleotide repeat on chromosome 5 that serves as a marker for microsatellite instability in colorectal cancers. ( NCI )] (UMLS (NCI) C1327771) D5S346 Dinucleotide Repeat =Gene or Genome; ;
| - 360. Dactinomycin/Melphalan
- (UMLS (NCI) C0879420) =Therapeutic or Preventive Procedure
|
- 311. DA
- [A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn). (NCI) ( NCI )] (UMLS (NCI) C0011318) =Geographic Area ;
| - 361. Daflon 500
- [Daflon 500 is a phlebotonic drug and a vascular protecting agent. It is reported to improve microcirculation in chronic venous insufficiency by improvement of venous tone, inhibition of prostaglandin synthesis, protection against free radicals, activation of the complement system, and increased lymphatic drainage. This results in reduced venous capacitance, distensibility, and emptying time; reduced capillary permeability; and increased capillary resistance. (Angiology 1994 Jun;45(6):419-2) ( NCI )] (UMLS (NCI) C0281764) =Organic Chemical; Pharmacologic Substance
|
- 312. DAB(389)IL-2
- (UMLS (NCI) C0211023) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 362. DAG/VP-16
- (UMLS (NCI) C0279354) =Therapeutic or Preventive Procedure
|
- 313. DAB2
- [This gene is involved in the regulation of cell proliferation. ( NCI )] (UMLS (NCI) C1333202) DAB2 Gene;
Disabled Homolog 2, Mitogen-Responsive Phosphoprotein (Drosophila) Gene =Gene or Genome ;
◊ [Encoded by human tumor suppressor DAB2 Gene, Disabled Homolog 2 Protein is expressed in ovarian, breast, and lung epithelial cells, spleen, thymus, prostate, testis, macrophages, fibroblasts, placenta, brainstem, heart, and small intestine. The 770-amino acid 82.5-kD predicted protein has 83% identity with mouse p96 protein, a putative mitogen-responsive phosphoprotein; strongest homology exists in the N-terminal PTB/PID domain. Potentially phosphorylated, DAB2 is a putative component of the CSF-1 cell proliferation signal transduction pathway. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1333302) DAB2 Protein; Differentially Expressed in Ovarian Cancer 2; Differentially Expressed Protein 2; Disabled Homolog 2; Disabled Homolog 2 Protein; Disabled Homolog 2, Mitogen-Responsive Phosphoprotein; DOC2; DOC-2; Mitogen-Responsive Phosphoprotein Amino Acid, Peptide, or Protein; Biologically Active Substance | - 363. Daily
- [Every day, at an unspecified time. ( NCI )] (UMLS (NCI) C0332173) =Temporal Concept
|
- 314. DAB389 EGF
- [A recombinant fusion protein composed of the diphtheria toxin with the receptor-binding domain replaced by human epidermal growth factor (EGF). When administered, EGF binds to the endothelial cell growth factor receptor, EGFR, which is upregulated in many solid tumors. After binding to the EGF receptor, the agent is internalized by the cell, where the diphtheria toxin moiety exerts its cytotoxic effect, inhibiting protein synthesis through ADP-ribosylation of elongation factor 2. (NCI04) ( NCI )] (UMLS (NCI) C0281573) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 364. Daily deductible information
- (UMLS (HL7) C1547344) =Idea or Concept =Data type;
|
- 315. Dabska Tumor
- [An intermediate, rarely metastasizing blood vessel neoplasm. It is characterized by the presence of lymphatic like vascular channels and papillary endothelial proliferation. ( NCI )] (UMLS (NCI) C0346087) =Neoplastic Process
| - 365. Daily Fill
- [A fill providing sufficient supply for one day ( HL7V3.0 )] (UMLS (HL7) C1553487) =Intellectual Product =First Fill;
Refill |
- 316. Dacarbazine/Doxorubicin
- (UMLS (NCI) C0050841) =Therapeutic or Preventive Procedure ;
| - 366. Dairy
- [Milk production ( HL7V3.0 )] (UMLS (HL7) C1547276) =Intellectual Product =Production Class Code;
LivingSubjectProductionClass |
- 317. Dacarbazine/Doxorubicin/Filgrastim/Ifosfamide
- (UMLS (NCI) C0281590) =Therapeutic or Preventive Procedure
| - 367. dairy product
- [raw and processed or manufactured milk and milk-derived products; usually from cows (bovine) but are also from goats, sheep, reindeer, and water buffalo. ( CSP )] (UMLS (CSP) C0010947) =Food ;
=food;
=MILK;
|
- 318. Dacarbazine/Doxorubicin/Ifosfamide
- (UMLS (NCI) C0280108) =Therapeutic or Preventive Procedure
| - 368. Dakhota
- (UMLS (HL7) C0574595) =Language =Dakotan;
|
- 319. Dacarbazine/Doxorubicin/Ifosfamide/Mesna
- (UMLS (NCI) C0338361) =Therapeutic or Preventive Procedure ;
| - 369. Dakotan
- (UMLS (HL7) C1698645) =Language =MississippiValley;
=Dakhota;
Lakhota;
Nakoda;
Assiniboin |
- 320. Dacarbazine/Doxorubicin/Ifosfamide/Sargramostim
- (UMLS (NCI) C0279309) =Therapeutic or Preventive Procedure
| - 370. Dalmane
- (UMLS (NCI) C0733803) =Organic Chemical; Pharmacologic Substance ;
|
- 321. Dacarbazine/Doxorubicin/Ifosfamide/SU5416
- (UMLS (NCI) C1134485) =Therapeutic or Preventive Procedure
| - 371. Dalmatian
- [The Dalmatian is a symmetrical, muscular medium-sized dog with superior endurance. It has a short, hard, dense coat of pure white with characteristic black or liver colored spots randomly splashed over it. The spots can be black, brown (liver), lemon, dark blue, tri colored, brindled, solid white, or sable. Height: 20-24 inches (50-60 cm.) Weight: about 55 pounds (25 kg.) ( NCI )] (UMLS (NCI) C0324355) =Mammal
|
- 322. Dacarbazine/Doxorubicin/Ifosfamide/Vincristine
- (UMLS (NCI) C0392976) =Therapeutic or Preventive Procedure ;
| - 372. Dalteparin/Gemcitabine
- (UMLS (NCI) C1134590) =Therapeutic or Preventive Procedure ;
|
- 323. Dacarbazine/Etoposide/Hydroxyurea
- (UMLS (NCI) C0278892) =Therapeutic or Preventive Procedure
| - 373. DAMAGE PELVIC JT-POSTPAR
- [ ] (UMLS (ICD9CM) C0157373) =Injury or Poisoning
|
- 324. Dacarbazine/Interferon Alfa
- (UMLS (NCI) C0338147) =Therapeutic or Preventive Procedure
| - 374. Damage To Ligament
- (UMLS (NCI) C0435001) =Injury or Poisoning
|
- 325. Dacarbazine/Interferon Alfa/Tamoxifen
- (UMLS (NCI) C0338148) =Therapeutic or Preventive Procedure
| - 375. Damage to nerve(s)
- [general term for injuries to nerves. ( CSP )] (UMLS (NCI) C0161479) =Injury or Poisoning =CNS DISORDER NOS;
injury =Injury, spinal cord |
- 326. Dacarbazine/Interleukin-1-Alpha
- (UMLS (NCI) C0281555) =Therapeutic or Preventive Procedure ;
| - 376. Damage to pelvic joints and ligaments, unspecified as to episode of care in pregnancy
- [ ] (UMLS (ICD9CM) C0157371) =Injury or Poisoning
|
- 327. Dacarbazine/Interleukin-2
- (UMLS (NCI) C0280740) =Therapeutic or Preventive Procedure
| - 377. Damage to pelvic joints and ligaments, with delivery
- [ ] (UMLS (ICD9CM) C0269891) =Injury or Poisoning ;
|
- 328. Dacarbazine/Interleukin-2/Temozolomide
- (UMLS (NCI) C1327795) =Therapeutic or Preventive Procedure ;
| - 378. Damage to pelvic organs and tissues following abortion or ectopic and molar pregnancies
- [ ] (UMLS (ICD9CM) C0495173) =Injury or Poisoning
|
- 329. Dacarbazine/Oblimersen
- (UMLS (NCI) C0935829) =Therapeutic or Preventive Procedure
| - 379. Damage to retina
- (UMLS (NCI) C0235272) =Disease or Syndrome
|
- 330. Dacarbazine/Pirarubicin
- (UMLS (NCI) C0338081) =Therapeutic or Preventive Procedure
| - 380. Damage, tissue
- (UMLS (NCI) C0010957) =Injury or Poisoning ;
|
- 331. Dacarbazine/Piritrexim
- (UMLS (NCI) C0279277) =Therapeutic or Preventive Procedure ;
| - 381. Damnacanthal
- [An alkaloid phytochemical found in the Morinda Citrifolia (Noni) that inhibits the growth of RAS cancer cells. The exact mechanism is unknown but may involve the inhibition of tyrosine kinase. (NCI) ( NCI )] (UMLS (NCI) C0212399) =Organic Chemical; Pharmacologic Substance
|
- 332. Dacarbazine/Tamoxifen
- (UMLS (NCI) C0280933) =Therapeutic or Preventive Procedure
| - 382. DAN Protein
- [DAN protein (Differential screening-selected gene Aberrant in Neuroblastoma) is a putative transcription factor that may prevent cells from entering final G1/S stage. (from OMIM 600613 and NCI) ( NCI )] (UMLS (NCI) C0251712) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 333. Dacarbazine/Temozolomide
- (UMLS (NCI) C1327794) =Therapeutic or Preventive Procedure ;
| - 383. Danaparoid Sodium
- [The sodium salt form of danaparoid, a synthetic low molecular weight heparin (LMWH) derived from porcine gut mucosa with anticoagulant activity. Danaparoid sodium binds to antithrombin III and inhibits the activity of activated factor X (factor Xa) and, to a lesser extent, activated factor II (thrombin) thereby preventing fibrin formation. Compared to heparin, danaparoid sodium exhibits a much higher ratio of anti-factor Xa activity to anti-factor IIa activity (22:1). ( NCI )] (UMLS (NCI) C0353453) =Organic Chemical; Pharmacologic Substance =danaparoid;
=DANAPAROID SODIUM 750 UNT/0.6ML |
- 334. Dacarbazine/Zorubicin
- (UMLS (NCI) C0279395) =Therapeutic or Preventive Procedure
| - 384. Dance Therapist
- [The dance therapist, sometimes called a movement therapist, focuses on rhythmic body movements as a medium of physical and psychological change. Dance therapy is practiced more often with mental health patients than with physically disabled patients. A master's degree is required by the American Dance Therapy Association to award the credentials Dance Therapist Registered (DTR).Source: Joel A. DeLisa and Bruce M. Gans, Rehabilitation Medicine: Principles and Practice Second Edition, J.B. Lippincott Company, Philadelphia: 1993, p. 11 ( HL7V3.0 )] (UMLS (HL7) C1609075) =Intellectual Product =Respiratory, Rehabilitative and Restorative Service Providers;
|
- 335. Dachshund
- [The Dachshund is an elongated, vigorous, muscular dog with short legs. This breed has a long muzzle and robust jaws with extremely strong canine teeth. There are two sizes of Dachshund: standard and miniature. Both sizes have three coat varieties: the short-haired, the wired-haired, and the long-haired. Solid-colored Dachshunds may be tan or yellow. Bi-color Dachshunds may be deep black, brown, or gray with areas of bright chestnut. There are also piebald, speckle-streaked, or harlequin varieties. Standard Height: 6-9 inches; Miniature Height: 5 inches. Weight: Standard 16-32 pounds (7-14 kg.); Miniature under 11 pounds (5 kg.) ( NCI )] (UMLS (NCI) C0324348) =Mammal
| - 385. dance therapy
- [The use of dancing for therapeutic purposes. ( MSH )] (UMLS (CSP) C0010962) =Therapeutic or Preventive Procedure ;
|
- 336. Dachshund - Long Haired Mini
- [The Long Haired Mini Dachshund is a long-haired variety of dachshund with a height up to 5 inches. ( NCI )] (UMLS (NCI) C0324349) =Mammal
| - 386. Dandie Dinmont Terrier
- [The Dandie Dinmont Terrier is longer than he is tall with short and muscular legs. The solid head is covered with a distinctive topknot. The unique crisp-textured coat contains a mixture of harsh and soft hair. It comes in two colors, pepper or mustard. The topknot and furnishings on pepper Dandies are silver and on mustard Dandies are cream colored. Height: 8-11 inches (20-28 cm.) Weight: 18-24 pounds (8-11 kg.) ( NCI )] (UMLS (NCI) C0324356) =Mammal
|
- 337. Dachshund - Long Haired Standard
- [The Long Haired Standard Dachshund is a long-haired variety of dachshund with a height of up to 9 inches. ( NCI )] (UMLS (NCI) C0324352) =Mammal
| - 387. Daniplestim
- [A synthetic cytokine and interleukin-3 (IL-3) receptor agonist with enhanced hematopoietic potency. Daniplestim exhibits 10- to 20-fold greater biological activity than recombinant human IL-3 in human hematopoietic cell proliferation and marrow colony-forming-unit assays. In contrast, this agent shows no significant increase in pro-inflammatory activity relative to native IL-3. The enhanced hematopoietic activity of daniplestim correlates with a 60-fold increase in IL-3 alpha-subunit binding affinity and 20-fold greater affinity for binding to alpha/beta receptor complexes on intact cells relative to recombinant IL-3. ( NCI )] (UMLS (NCI) C0297038) =Amino Acid, Peptide, or Protein ;
|
- 338. Dachshund - Smooth Haired Mini
- [The Smooth Haired Mini Dachshund is a smooth-haired variety of dachshund with a height up 5 inches. ( NCI )] (UMLS (NCI) C0324350) =Mammal
| - 388. Danoval
- (UMLS (NCI) C0733892) =Steroid; Pharmacologic Substance ;
|
- 339. Dachshund - Smooth Haired Standard
- [The Smooth Haired Standard Dachshund is a smooth-haired variety of dachshund with a standard height up to 9 inches. ( NCI )] (UMLS (NCI) C0324353) =Mammal
| - 389. dantrolene
- [skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber; it is used in spasticity and other neuromuscular abnormalities. ( CSP )] (UMLS (CSP) C0010976) =Organic Chemical; Pharmacologic Substance =hydantoin;
[MS200] SKELETAL MUSCLE RELAXANTS;
Muscle Relaxant;
=DANTROLENE SODIUM;
|
- 340. Dachshund - Wire Haired Mini
- [The Wire Haired Mini Dachshund is a wire-haired variety of dachshund with a height up to 5 inches. ( NCI )] (UMLS (NCI) C0324351) =Mammal
| - 390. DAP
- [ ] (UMLS (CSP) C0596431) =Organic Chemical =aminopyrimidine;
=2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine;
2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine |
- 341. Dachshund - Wire Haired Standard
- [The Wire Haired Standard Dachshund is a wire-haired variety of dachshund with a standard height up to 9 inches. ( NCI )] (UMLS (NCI) C0324354) =Mammal
| - 391. Daphnia
- [A diverse genus of minute freshwater CRUSTACEA, of the suborder CLADOCERA. They are a major food source for both young and adult freshwater fish. ( MSH )] (UMLS (CSP) C0010979) =Invertebrate ;
|
- 342. Daclizumab/Interleukin-2
- (UMLS (NCI) C0796499) IL-2/MOAB anti-Tac;
Interleukin-2/Monoclonal Antibody Anti-Tac =Therapeutic or Preventive Procedure ;
| - 392. DAPK1
- [This gene is involved in pro-apoptotic regulation. ( NCI )] (UMLS (NCI) C1413906) DAPK1 Gene;
Death-Associated Protein Kinase 1 Gene =Gene or Genome |
- 343. Daclizumab/Methylprednisolone
- (UMLS (NCI) C1327874) =Therapeutic or Preventive Procedure ;
| - 393. dapsone/TMTX
- (UMLS (NCI) C0279251) =Therapeutic or Preventive Procedure ;
|
- 344. dacron
- [ ] (UMLS (CSP) C0947693) =Organic Chemical; Biomedical or Dental Material ;
| - 394. Daraprim
- (UMLS (NCI) C0591326) =Organic Chemical; Pharmacologic Substance ;
|
- 345. Dacryoadenitis
- [ ] (UMLS (ICD9CM) C0155223) =Disease or Syndrome ;
| - 395. Darbepoetin Alfa
- [(dar-be-POE-e-tin AL-fa) A substance made in the laboratory that stimulates the bone marrow to produce red blood cells. It belongs to the family of drugs called antianemics. ( NCI )] (UMLS (NCI) C0937950) NESP;
Novel Erythropoiesis Stimulating Protein =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 346. dacryocystitis
- [Inflammation of the lacrimal sac. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0010930) =Disease or Syndrome ;
=Disorders of lacrimal system;
| - 396. Darier's disease
- [slowly progressive autosomal dominant disorder of keratinization with papules on the seborrheic areas of the body that coalesce to form plaques which may become crusted and secondarily infected; lesions may darken and fuse over time to form papillomatous and warty malodorous growths. ( CSP )] (UMLS (CSP) C0022595) =Disease or Syndrome ;
=Genetic Condition;
keratosis;
Congenital anomalies of the integument;
Skin Diseases, Genetic |
- 347. Dacryocystogram
- (UMLS (HL7) C1548845) =Intellectual Product =Consent Type;
| - 397. DARIFENACIN
- (UMLS (NCI) C0529351) =Organic Chemical; Pharmacologic Substance
|
- 348. DACRYOCYSTORHINOSTOMY
- [Surgical fistulization of the lacrimal sac for external drainage of an obstructed nasolacrimal duct. ( MSH )] (UMLS (ICD9CM) C0010931) =Therapeutic or Preventive Procedure ;
| - 398. dark adaptation
- [adaptation of the eye to vision in the dark or in reduced illumination (night vision), with build-up of rhodopsin in the retinal rods; called also scotopic adaptation. ( CSP )] (UMLS (CSP) C0010985) =Organ or Tissue Function ;
=retinal adaptation;
|
- 349. DACRYOLITH
- [ ] (UMLS (ICD9CM) C0155249) =Body Substance ;
| - 399. DARK ADAPTATION STUDY
- (UMLS (ICD9CM) C0200161) =Diagnostic Procedure
|
- 350. DACRYOPS
- [ ] (UMLS (ICD9CM) C0155227) =Sign or Symptom ;
| - 400. dark-field microscope
- [A microscope (device used to magnify small objects) in which objects are lit at a very low angle from the side so that the background appears dark and the objects show up against this dark background. ( NCI )] (UMLS (NCI) C0687391) =Medical Device
|
home
